Democrats escalate probe of Trump admin drug pricing deals

AI Summary

Congressional Democrats are pressing pharmaceutical companies to disclose the unredacted terms of their most-favored-nation drug pricing agreements with the Trump administration. The effort is being led by lawmakers who may take senior health-policy roles in Congress next year.

Congressional Democrats are demanding pharmaceutical companies immediately disclose the un-redacted details of their “most favored nation” agreements with the Trump administration, according to a source familiar with the effort.  The request to drugmakers comes from the potential health policy leaders in Congress next year — Democratic Reps. Frank Pallone Jr. (N.J.) of the Energy and…